Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome.
Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, Nakamura H, Berean K, Hovan A, Le ND, Hislop G, Priddy R, Hay J, Lam WL, Rosin MP.
Zhang L, et al. Among authors: priddy r.
Cancer Res. 2005 Sep 1;65(17):8017-21. doi: 10.1158/0008-5472.CAN-04-3153.
Cancer Res. 2005.
PMID: 16140975